tirzepatide shortage fda update news today says the weight-loss drug is over Lilly Updates Open Letter Regarding – FDA Announced Removal of Tirzepatide

Even in cases of lower adherence, patients maintained glycaemic and weight control, highlighting the flexibility and effects of oral semaglutide

Greenblatt MB, Tsai JN, Wein MN (2017) Bone turnover markers in the diagnosis and monitoring of metabolic bone disease

O.et al (2019)

4.4 Autoimmune hepatitis (AIH) Autoimmune hepatitis (AIH) is a type of liver inflammation characterized by the immune system attacking hepatocytes, leading to chronic liver injury (Terziroli Beretta-Piccoli et al., 2022

Pharmacological alternatives that have evidence for binge eating disorder include: Lisdexamfetamine : Licensed in some countries specifically for moderate-to-severe BED in adults, though it is not licensed for this indication in the UK and is not recommended by NICE for BED